The impact of ionic liquid formation on the activity, solubility and pharmacokinetics of rifampicin
Abstract
Rifampicin (RIF) is a key first-line antitubercular agent. However, its clinical utility is hindered by poor solubility and suboptimal oral absorption. When paired with oppositely charged citric acid (CA) at 1:5 molar ratio, the interaction yields an active pharmaceutical ingredient ionic liquid (API-IL); RIF-CA IL. This transformation resulted in a new liquid form that modulated RIF’s physicochemical properties. This study explores the pharmaceutical and biological properties of a RIF-CA IL, 1:5. The conditions of the solvent-evaporation method were found to be critical for its stability and antimicrobial activity. Spectroscopic analyses confirmed IL formation and significant intermolecular interactions. RIF-CA IL exhibited improved wettability and hydrophilicity, resulting in a 20-fold increase in RIF saturation solubility. The IL had comparable cytotoxicity and cellular uptake to RIF in A549 lung cells. A Novel greenness-assisted HPLC method was developed to precisely and selectively determine rifampicin levels in serum. An in-vivo pharmacokinetic study in rabbits demonstrated a more than 2.2-fold increase in oral bioavailability compared to native RIF. Notably, these enhancements were not observed with a physical mixture of RIF and CA at the same molar ratio. These results suggest RIF-CA IL is a promising alternative to conventional RIF form with comparable bioactivity, yet superior bioavailability.
Related
- The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis
- Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials
- Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia.
- Impact of GPR39 Inhibition on Tissue Oxygen Tension in Acute Myocardial Infarction: Modeling Using an Indirect Response Pharmacokinetics/Pharmacodynamics Approach
- Design and Evaluation of Ethylene Glycol Monopiperate as a Novel Antihyperlipidemic Prodrug: Synthesis, Antihyperlipidemic Activity, and Pharmacokinetics.
BibTeX
@article{rasmy2026impact,
title = {{The impact of ionic liquid formation on the activity, solubility and pharmacokinetics of rifampicin}},
author = {Hanan E. Rasmy and Yasmin N. Ramadan and Heba Salah Mousa and Helal F. Hetta and Elsayed A. Ibrahim and Sara A. Abouelmagd},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-72363-8},
url = {https://www.nature.com/articles/s41598-026-72363-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The impact of ionic liquid formation on the activity, solubility and pharmacokinetics of rifampicin
AU - Hanan E. Rasmy
AU - Yasmin N. Ramadan
AU - Heba Salah Mousa
AU - Helal F. Hetta
AU - Elsayed A. Ibrahim
AU - Sara A. Abouelmagd
PY - 2026
DA - 2026/10/15
JO - Scientific Reports
DO - 10.1038/s41598-026-72363-8
UR - https://www.nature.com/articles/s41598-026-72363-8
AB - Rifampicin (RIF) is a key first-line antitubercular agent. However, its clinical utility is hindered by poor solubility and suboptimal oral absorption. When paired with oppositely charged citric acid (CA) at 1:5 molar ratio, the interaction yields an active pharmaceutical ingredient ionic liquid (API-IL); RIF-CA IL. This transformation resulted in a new liquid form that modulated RIF’s physicochemical properties. This study explores the pharmaceutical and biological properties of a RIF-CA IL, 1:5. The conditions of the solvent-evaporation method were found to be critical for its stability and antimicrobial activity. Spectroscopic analyses confirmed IL formation and significant intermolecular interactions. RIF-CA IL exhibited improved wettability and hydrophilicity, resulting in a 20-fold increase in RIF saturation solubility. The IL had comparable cytotoxicity and cellular uptake to RIF in A549 lung cells. A Novel greenness-assisted HPLC method was developed to precisely and selectively determine rifampicin levels in serum. An in-vivo pharmacokinetic study in rabbits demonstrated a more than 2.2-fold increase in oral bioavailability compared to native RIF. Notably, these enhancements were not observed with a physical mixture of RIF and CA at the same molar ratio. These results suggest RIF-CA IL is a promising alternative to conventional RIF form with comparable bioactivity, yet superior bioavailability.
SN - 2045-2322
ER -